Skip to product information
1 of 1

Bruschettini

Lacteol 10 billion oral powder + 5 billion hard capsules 20 capsules

Lacteol 10 billion oral powder + 5 billion hard capsules 20 capsules

Regular price €20,43
Regular price €21,50 Sale price €20,43
Sale Sold out
VAT included. Shipping calculated at checkout.
Logo Farmaci da banco

NET WEIGHT OF THE PRODUCT

20ct

EAN

028962013

MINSAN

028962013

View full details

In compliance with article 118 "authorization of advertising to the public" of the legislative decree of 24 April 2006, number 219

INDICATIONS

Diarrheal and dyspeptic syndromes due to altered bacterial flora (diarrhoea, non-specific enteritis in infants and adults, colitis). Intestinal dysmicrobism caused by antibiotics. Digestive disorders in artificially fed infants. Adjuvant in the elimination of pathogenic enterobacteria resistant to chemoantibiotics.

CONTRAINDICATIONS

Individual hypersensitivity to the drug.

WARNINGS AND PRECAUTIONS FOR USE

Keep out of the sight and reach of children. In the case of symptoms in infants, it is necessary to consult the doctor in order to exclude differential diagnoses. N.B.: the product must be used together with rehydration therapy, particularly in children under the age of two years. The degree and method of rehydration (oral or intravenous) must be established by the doctor who will evaluate the severity of the diarrhea, the age and health conditions of the patient. LACTEOL capsules and LACTEOL sachets contain lactose, patients suffering from rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medicine. LACTEOL sachets contain sucrose, patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine.

INTERACTIONS

No interactions have been reported with the use of other systemic or topical drugs.

SIDE EFFECTS

They are not known. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/web/guest/content/segnalazioni-reazioni-avverse

1 of 4

Content Responsibility This sheet contains information that is not intended to replace a diagnosis or medical advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first. Please note The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the MINSAN ministerial code. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the information published. Data source: Farmadati Italia Website: www.farmadati.it The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory. The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.